Gunnar Birgegård
- Hematology top 0.2%
- Genetics top 0.2%
- Molecular Biology top 10%
- Rheumatology top 1%
- Oncology top 5%
- Co-authors
- Leif WideHeinz LudwigPere GascónTiziano BarbuiGiovanni BarosiCarsten BokemeyerMaciej KrzakowskiM. Schneider
- Topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers)Erythropoietin and Anemia Treatment (35 papers)Iron Metabolism and Disorders (35 papers)
- Cited by
- HematologyGeneticsRheumatology
In The Last Decade
Gunnar Birgegård
119 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Hematology 3.1k
- Genetics 2.6k
- Molecular Biology 1.2k
- Rheumatology 859
- Oncology 557
Countries citing papers authored by Gunnar Birgegård
This map shows the geographic impact of Gunnar Birgegård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Birgegård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Birgegård more than expected).
Fields of papers citing papers by Gunnar Birgegård
This network shows the impact of papers produced by Gunnar Birgegård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Birgegård. The network helps show where Gunnar Birgegård may publish in the future.
Co-authorship network of co-authors of Gunnar Birgegård
This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Birgegård. A scholar is included among the top collaborators of Gunnar Birgegård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Birgegård. Gunnar Birgegård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 1 | |
| 3 | Rate Of Malignant Transformation In High Risk Et During 5 Years Of Follow-Up Of Cytoreductive Therapy | 1 |
| 4 | RISK FACTORS FOR THROMBOHEMORRHAGIC AND TRANSFORMATION EVENTS IN 3649 HIGH-RISK PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA : RESULTS FROM THE PROSPECTIVE LONG-TERM OBSERVATIONAL EXELS STUDY | 1 |
| 5 | 10 | |
| 6 | 20 | |
| 7 | 5 | |
| 8 | 12 | |
| 9 | 174 | |
| 10 | 49 | |
| 11 | 43 | |
| 12 | 18 | |
| 13 | Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelbreakdown → | 604 |
| 14 | 80 | |
| 15 | 71 | |
| 16 | 78 | |
| 17 | 46 | |
| 18 | Biochemical indices of calcium homeostasis immediately after kidney transplantation | 1 |
| 19 | 21 | |
| 20 | 22 |
About Gunnar Birgegård
Gunnar Birgegård is a scholar working on Hematology, Genetics and Biochemistry, having authored 121 papers that have together received 4.8k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers), Erythropoietin and Anemia Treatment (35 papers) and Iron Metabolism and Disorders (35 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (2.6k citations) and Rheumatology (859 citations). Gunnar Birgegård has collaborated with scholars based in Sweden, Germany and Italy. Frequent co-authors include Leif Wide, Heinz Ludwig, Pere Gascón, Tiziano Barbui, Giovanni Barosi, Carsten Bokemeyer, Maciej Krzakowski, M. Schneider, Dirk Schrijvers and Alessandro M. Vannucchi. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.